sudden
increas
case
put
high
pressur
healthcar
servic
worldwid
current
stage
fast
accur
earli
clinic
assess
diseas
sever
vital
support
decis
make
logist
plan
healthcar
system
studi
leverag
databas
blood
sampl
infect
patient
region
wuhan
china
identifi
crucial
predict
biomark
diseas
sever
purpos
machin
learn
tool
select
three
biomark
predict
surviv
individu
patient
accuraci
lactic
dehydrogenas
ldh
lymphocyt
highsensit
creactiv
protein
hscrp
particular
rel
high
level
ldh
alon
seem
play
crucial
role
distinguish
vast
major
case
requir
immedi
medic
attent
find
consist
current
medic
knowledg
high
ldh
level
associ
tissu
breakdown
occur
variou
diseas
includ
pulmonari
disord
pneumonia
overal
paper
suggest
simpl
oper
formula
quickli
predict
patient
highest
risk
allow
prioritis
potenti
reduc
mortal
rate
outbreak
epidem
caus
worldwid
health
concern
sinc
decemb
viru
caus
fever
cough
fatigu
mild
sever
respiratori
complic
eventu
lead
patient
death
march
total
amount
cumul
infect
case
world
death
march
viru
outbreak
declar
pandem
world
health
organ
viru
spread
countri
total
record
case
death
far
report
infect
patient
prone
develop
critic
ill
case
furthermor
recent
report
expos
astonish
case
fatal
rate
critic
case
increas
sharpli
age
patient
underli
comorbid
reach
sever
case
put
great
pressur
medic
servic
readili
lead
shortag
intens
care
resourc
unfortun
far
current
avail
prognost
biomark
distinguish
patient
requir
immedi
medic
attent
associ
mortal
rate
capac
distinguish
case
immin
risk
mortal
therefor
becom
urgent
yet
challeng
necess
circumst
retrospect
analys
blood
sampl
patient
region
wuhan
china
identifi
robust
meaning
marker
mortal
risk
purpos
mathemat
model
approach
base
stateoftheart
interpret
machin
learn
algorithm
devis
identifi
discrimin
biomark
patient
surviv
problem
formul
classif
task
input
basic
inform
symptom
blood
sampl
laboratori
test
includ
liver
function
kidney
function
coagul
function
electrolyt
inflammatori
factor
taken
origin
gener
sever
critic
patient
tabl
associ
outcom
correspond
either
surviv
death
end
examin
period
optim
classifi
aim
reveal
crucial
biomark
distinguish
patient
immin
risk
therebi
reliev
clinic
burden
potenti
reduc
mortal
rate
medic
record
collect
use
standard
case
report
form
includ
epidemiolog
demograph
clinic
laboratori
drug
nurs
mortal
outcom
tabl
clinic
outcom
follow
februari
studi
approv
tongji
hospit
ethic
committe
consid
medic
inform
patient
collect
januari
februari
data
origin
pregnant
breastfeed
women
patient
younger
year
old
record
without
least
complet
data
materi
exclud
subsequ
analysi
remain
patient
recov
viru
remain
die
high
mortal
rate
relat
fact
tongji
hospit
admit
sever
case
wuhan
upon
admiss
patient
sever
empir
assess
medic
doctor
accord
rule
tabl
figur
summaris
outcom
patient
three
differ
classif
one
epidemiolog
histori
live
wuhan
within
day
onset
contact
patient
fever
respiratori
symptom
wuhan
within
day
onset
fever
andor
respiratori
symptom
normal
decreas
total
white
blood
cell
count
decreas
lymphocyt
count
earli
stage
onset
typic
imag
featur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
need
mechan
ventil
admit
icu
mod
figur
valid
set
chosen
sever
patient
sinc
unpredict
term
clinic
outcom
tabl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
concentr
trend
continu
variabl
fit
nonnorm
distribut
median
describ
concentr
trend
patient
taken
multipl
blood
sampl
throughout
stay
hospit
model
train
test
use
last
avail
record
patient
input
model
assess
crucial
biomark
diseas
sever
distinguish
patient
requir
immedi
medic
assist
accur
match
correspond
featur
label
miss
data
pad
model
output
correspond
patient
surviv
patient
surviv
assign
class
die
class
case
use
develop
model
first
separ
train
test
set
follow
ratio
crossvalid
time
figur
perform
model
evalu
assess
classif
accuraci
ratio
true
predict
predict
precis
sensitivityrecal
score
defin
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
studi
use
supervis
xgboost
classifi
predictor
model
xgboost
highperform
machin
learn
algorithm
benefit
great
interpret
potenti
due
recurs
treebas
decis
system
contrast
intern
model
mechan
blackbox
model
strategi
typic
difficult
interpret
import
individu
featur
xgboost
determin
accumul
use
decis
step
tree
comput
metric
character
rel
import
featur
particularli
valuabl
estim
featur
discrimin
model
outcom
especi
relat
meaning
clinic
paramet
xgboost
origin
train
default
paramet
set
max
depth
equal
learn
rate
equal
number
tree
estim
set
valu
regular
paramet
set
subsampl
colsamplebytre
set
prevent
overfit
case
mani
featur
small
sampl
size
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
number
top
featur
increas
henc
number
key
featur
set
follow
ldh
lymphocyt
hscrp
tabl
perform
xgboost
classif
discrimin
mortal
outcom
follow
previou
find
import
ldh
lymphocyt
hscrp
next
step
construct
simplifi
clinic
oper
decis
model
xgboost
algorithm
base
recurs
decis
tree
build
past
residu
identifi
tree
contribut
decis
predict
model
decis
tree
simpl
classifi
consist
sequenc
binari
decis
organ
hierarch
singl
decis
tree
intuit
appeal
sinc
base
recurs
dichotom
partit
data
follow
optim
separ
decis
rule
node
henc
accuraci
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
tree
remain
high
reduc
complex
model
structur
potenti
reveal
clinic
portabl
decis
algorithm
refer
latter
explain
model
singletre
xgboost
total
patient
incomplet
measur
least
one
three
princip
biomark
leav
patient
identifi
singletre
xgboost
model
identifi
model
xgboost
retrain
paramet
describ
except
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
perform
model
extern
valid
data
part
train
test
model
found
tabl
associ
confus
matrix
shown
left
figur
show
death
predict
accuraci
surviv
predict
accuraci
confus
matrix
right
figur
final
patient
taken
multipl
blood
sampl
throughout
stay
hospit
total
blood
sampl
complet
measur
three
featur
train
test
set
patient
plu
blood
sampl
valid
set
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
valid
model
addit
blood
test
supplementari
figur
overal
accuraci
show
model
appli
blood
sampl
even
far
patient
clinic
outcom
three
select
featur
surviv
dead
patient
seen
supplementari
figur
signific
work
twofold
first
goe
beyond
provid
highrisk
factor
provid
simpl
intuit
clinic
test
precis
quickli
quantifi
risk
death
exampl
routin
sequenti
respiratori
support
therapi
patient
intranas
catheter
oxygen
oxygen
suppli
mask
high
flow
oxygen
suppli
nasal
cathet
noninvas
ventil
support
invas
ventil
support
ecmo
predict
patient
sequenti
oxygen
therapi
lead
unsatisfactori
therapeut
effect
could
preempt
physician
pursuit
differ
approach
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
goal
model
identifi
highrisk
patient
irrevers
lesion
occur
second
three
key
featur
ldh
lymphocyt
hscrp
easili
collect
hospit
crow
hospit
shortag
medic
resourc
simpl
model
help
quickli
prioritis
patient
increas
ldh
reflect
tissuecel
destruct
regard
common
sign
tissuecel
damag
serum
ldh
identifi
import
biomark
activ
sever
idiopath
pulmonari
fibrosi
ipf
patient
sever
pulmonari
interstiti
diseas
increas
ldh
signific
one
import
prognost
marker
lung
injuri
critic
ill
patient
rise
ldh
level
indic
increas
activ
extent
lung
injuri
higher
serum
hscrp
could
also
use
predict
risk
death
sever
patient
increas
hscrp
import
marker
poor
prognosi
ard
reflect
persist
state
inflamm
result
persist
inflammatori
respons
larg
greywhit
lesion
lung
patient
seen
autopsi
tissu
section
larg
amount
sticki
secret
also
seen
overflow
alveoli
final
result
also
suggest
lymphocyt
may
serv
potenti
therapeut
target
hypothesi
support
result
clinic
studi
moreov
lymphopenia
common
featur
patient
might
critic
factor
associ
diseas
sever
mortal
injur
alveolar
epitheli
cell
could
induc
infiltr
lymphocyt
lead
persist
lymphopenia
sarscov
merscov
given
share
similar
alveolar
penetr
antigen
present
cell
apc
impair
pathway
biopsi
studi
provid
strong
evid
count
peripher
cell
substanti
reduc
statu
hyperactiv
also
jing
colleagu
report
lymphopenia
mainli
relat
decreas
cell
thu
like
lymphocyt
play
distinct
role
deserv
investig
studi
room
improv
first
sinc
propos
machin
learn
method
pure
data
driven
model
may
vari
start
differ
dataset
data
becom
avail
whole
procedur
easili
repeat
obtain
accur
model
singlecentr
retrospect
studi
provid
preliminari
assess
clinic
cours
outcom
sever
patient
although
origin
databas
cover
patient
clinic
outcom
yet
releas
time
studi
look
forward
subsequ
larg
sampl
multicentr
studi
second
although
pool
clinic
measur
model
principl
tradeoff
minim
number
featur
capac
good
predict
therefor
avoid
overfit
final
studi
strike
balanc
model
interpret
improv
accuraci
clinic
set
tend
prefer
interpret
model
possibl
black
box
model
may
lead
improv
perform
recent
data
base
retrospect
blood
sampl
collect
patient
infect
tongji
hospit
wuhan
china
use
identifi
predict
potenti
lifesav
discrimin
biomark
patient
within
critic
condit
rang
stateoftheart
machin
learn
framework
suggest
diseas
sever
accur
predict
use
three
biomark
therefor
greatli
reduc
space
clinic
paramet
monitor
associ
medic
burden
summari
studi
identifi
three
indic
ldh
hscrp
lymphocyt
threshold
ldh
hscrp
lymphocyt
prognost
predict
develop
xgboost
machin
learningbas
prognost
model
predict
surviv
rate
sever
patient
accuraci
use
last
sampl
blood
sampl
enabl
detect
earli
intervent
potenti
reduct
mortal
highrisk
patient
technic
point
view
work
help
pave
way
use
machin
learn
method
predict
diagnosi
triag
larg
scale
explos
epidem
case
b
acya
b
return
els
z
z
return
step
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
train
paramet
set
max
depth
learn
rate
equal
valu
regular
paramet
set
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
step
reduc
number
tree
lead
singletre
xgboost
algorithm
sampl
least
one
featur
miss
order
obtain
better
decis
rule
delet
sampl
obtain
new
dataset
sampl
featur
singletre
xgboost
sampl
featur
train
paramet
set
tress
number
estim
set
valu
two
regular
paramet
set
subsampl
max
featur
set
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
